GeneOne Life Science Inc (011000) — Net Asset Quality Index
GeneOne Life Science Inc (011000) has a Net Asset Quality Index of 34.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩119.21 Billion minus total liabilities of ₩78.31 Billion yields net assets of ₩40.90 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See GeneOne Life Science Inc (011000) liquidity interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
GeneOne Life Science Inc Net Asset Quality Index Over Time (2009–2025)
This chart shows how GeneOne Life Science Inc's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2025. As of December 2025, the index stands at 34.3%, representing net assets of ₩40.90 Billion against total assets of ₩119.21 Billion KRW. Explore GeneOne Life Science Inc cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for GeneOne Life Science Inc (2009–2025)
The table below presents the year-by-year Net Asset Quality Index for GeneOne Life Science Inc from 2009 to 2025, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see GeneOne Life Science Inc (011000) market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.3% | ₩40.90 Billion | ₩119.21 Billion | ₩78.31 Billion | ▼ -22.3 pp |
| 2024 | 56.6% | ₩85.61 Billion | ₩151.33 Billion | ₩65.73 Billion | ▼ -17.3 pp |
| 2023 | 73.8% | ₩111.49 Billion | ₩151.01 Billion | ₩39.52 Billion | ▼ -7.6 pp |
| 2022 | 81.4% | ₩181.47 Billion | ₩222.87 Billion | ₩41.40 Billion | ▼ -0.9 pp |
| 2021 | 82.3% | ₩205.45 Billion | ₩249.50 Billion | ₩44.04 Billion | ▲ +10.2 pp |
| 2020 | 72.1% | ₩98.51 Billion | ₩136.57 Billion | ₩38.06 Billion | ▲ +25.1 pp |
| 2019 | 47.0% | ₩24.06 Billion | ₩51.15 Billion | ₩27.09 Billion | ▼ -12.6 pp |
| 2018 | 59.7% | ₩29.41 Billion | ₩49.30 Billion | ₩19.89 Billion | ▼ -20.4 pp |
| 2017 | 80.1% | ₩36.54 Billion | ₩45.63 Billion | ₩9.09 Billion | ▲ +25.5 pp |
| 2016 | 54.6% | ₩35.85 Billion | ₩65.66 Billion | ₩29.81 Billion | ▼ -28.1 pp |
| 2015 | 82.7% | ₩39.44 Billion | ₩47.69 Billion | ₩8.25 Billion | ▼ -2.5 pp |
| 2014 | 85.2% | ₩34.73 Billion | ₩40.77 Billion | ₩6.03 Billion | ▲ +10.7 pp |
| 2013 | 74.5% | ₩23.71 Billion | ₩31.82 Billion | ₩8.11 Billion | ▲ +7.6 pp |
| 2012 | 66.9% | ₩26.74 Billion | ₩39.96 Billion | ₩13.22 Billion | ▼ -16.6 pp |
| 2011 | 83.5% | ₩33.79 Billion | ₩40.46 Billion | ₩6.67 Billion | ▲ +3.5 pp |
| 2010 | 80.0% | ₩32.04 Billion | ₩40.05 Billion | ₩8.02 Billion | ▲ +12.7 pp |
| 2009 | 67.3% | ₩39.74 Billion | ₩59.04 Billion | ₩19.30 Billion | — |